============================================================
CHUNK 0
============================================================
Paul N Newton, Nicholas PJ Day
typhus is misleading, as the disease can be contracted in many other habitats, including primary forest, beaches, gardens, and plantations. Indian patients with scrub typhus are more likely to have lived close to bushes and wood piles, to have worked on farms, to have seen rodents and to have reared domestic animals, but are less likely to wash  or  change  clothes  after  work.  For  Koreans,  wearing  a  longsleeved shirt while working, keeping work clothes off the grass and always using a mat to rest on outdoors were protective [4].
The most commonly reported serotypes are Karp, Kato, Gilliam, and Boryong, but the wide phenotypic and genotypic diversity of Orientia tsutsugamushi has major implications for the design of diagnostic tests and vaccines [1].

============================================================
CHUNK 1
============================================================
NATURAL HISTORY, PATHOGENESIS, AND PATHOLOGY
Scrub  typhus  is  transmitted  by  chiggers  -  the  third-stage  larvae  of Leptotombidium mites (Fig. 63.2), which feed on the extracellular fluid of vertebrates such as rodents and humans. Mites are the main reservoir of O. tsutsugamushi , with the organisms maintained in the population by transovarial transmission. Blood transfusion and needlestick injury have been recorded as transmitting scrub typhus.
The genome of O. tsutsugamushi (~2 million bp) is much larger than that  of  other  members  of  Rickettsiaceae  and  is  the  most  highly repeated  bacterial  genome  sequenced  [1].  The  median O.  tsutsugamushi DNA load in blood is low (~13 [0-310,253] copies/ml); approximately half of patients have bacterial loads undetectable by current techniques [5]. Post-mortem examination has demonstrated O. tsutsugamushi in  endothelial  cells  of  major  organs.  Significantly higher concentrations of gamma interferon and interleukin-10 occur during the  acute  than  the  convalescent  phase.  Comparison  of  patterns  of endothelial and leukocyte activation in a range of 'typhus-like' illnesses suggest mononuclear cell activation in scrub typhus. Evidence is accumulating that O. tsutsugamushi exhibits tropism for mononuclear cells rather than endothelial cells, at least in early infection [6]. Intriguingly, evidence from Thailand suggests that HIV-1-suppressive factors are produced during some scrub typhus infections.

============================================================
CHUNK 2
============================================================
CLINICAL FEATURES
The incubation period is approximately 6-14 days. Ten to fifty percent of patients may have an eschar - this variability probably reflects, at least  in  part,  the  extent  to  which  patients  are  examined.  Eschars, which are usually single and in secluded areas such as the axilla and groin, are painless, erythematous papules that develop a central black scab, resembling a cigarette burn (Fig. 63.3). They are not pathognomonic for scrub typhus, as similar lesions may be produced by spotted fever group  rickettsioses. Chiggers are minute and, unlike ticks, are not normally noticed. Patients may scratch off the characteristic black scab. Lymphadenopathy is more frequent than in sympatric murine typhus  [2].  Headache,  myalgia,  and  dry  cough  frequently  occur;  a maculopapular erythematous rash occurs in a minority  of  patients [1,2].  Deafness,  tinnitus,  and  conjunctival  suffusion  occur.  Severe

============================================================
CHUNK 3
============================================================
Key features
- Common, but under-recognized, cause of undi*erentiated fever in Asia and Australia caused by Orientia tsutsugamushi , with some one billion people at risk
- May also cause severe disease, such as meningoencephalitis, pneumonitis, jaundice, hypotensive shock, and death
- Transmitted by the bite of larval trombiculid mites (chiggers) in a wider diversity of habitats than 'scrub' suggests
- Can be di+cult to diagnose clinically; laboratory tests are inadequate
- There is evidence for tetracycline- and chloramphenicolresistant O. tsutsugamushi in northern Thailand. Elsewhere, tetracyclines, chloramphenicol, and rifampicin appear e+cacious
- Synonyms: tsutsugamushi disease, chigger-borne rickettsiosis

============================================================
CHUNK 4
============================================================
INTRODUCTION
Scrub typhus was described in Japan in the 1800s and then in Malaysia in the 1920s, where it was distinguished from murine typhus. It was a major clinical problem in many Asian theaters of the Second World  War  and  the  Indochina  Wars  [1].  Management  was  transformed  by  chloramphenicol  and  tetracyclines.  It  remains  a  major, under-appreciated cause of undifferentiated fever in Asia. Diagnosis is greatly hampered by the lack of accurate and accessible laboratory diagnosis.  Given  the  large  populations  of  India  and  China,  the numbers potentially exposed are enormous. With the growth of ecotourism in Asia, more travelers are returning to  non-endemic areas with this disease.

============================================================
CHUNK 5
============================================================
EPIDEMIOLOGY
Scrub typhus occurs in the most populous rural areas of the world - across 13,000,000 km 2 from the Pacific rim, Southeast Asia, northern Australia and Northeast Asia across South and Central Asia as far west as Uzbekistan and including the Maldives (Fig. 63.1) [1]. This has been conventionally called the 'scrub typhus triangle', but it is more of a rhomboid than a triangle. There are no reliable estimates of community incidence and most are hospital-derived, such as recent data that 3% of patients in Nepal and 15% of patients in Laos admitted with undifferentiated fever had scrub typhus [2, 3]. It predominantly afflicts farmers, including their children, but may also affect urban populations through exposure in gardens or visits to the countryside. There are no known genetic predispositions. The name scrub
cm
FIGURE  63.1 Map  of  the  distribution  of  scrub typhus. Please note that this map  disguises considerable  heterogeneity  between  and  within countries. ?, areas where the extent of scrub typhus is uncertain.
FIGURE 63.2 The life cycle of O. tsutsugamushi . Reproduced with permission from Audy JR, Red Mites and Typhus. Published by The Athlone Press, University of London, 1968.
disease  can  manifest  as pneumonitis,  acute  respiratory  distress syndrome,  jaundice  with  mildly  raised  transaminases,  meningoencephalitis, coagulopathy, multi-organ failure, acute renal failure, acute transverse myelitis,  myocarditis, and Guillain-Barr√©  syndrome. Why some, and not others, develop severe disease is not understood. Mortality  is  positively  correlated  with  blood  bacterial load  [5]. Orientia tsutsugamushi DNA  has  been  demonstrated  in  cerebrospinal  fluid (CSF),  with  normal  glucose,  a  mild  increase  in  white  cell  density (ranging from 11-88% lymphocytes) and raised protein [7]. Scrub typhus appears to be less severe in children, but there have been no
FIGURE 63.3 An  eschar  on  a  Lao  patient  with  scrub typhus. Taken by Dr Rattanaphone Phetsouvanh.

============================================================
CHUNK 6
============================================================
EPIDEMIOLOGY
prospective comparisons between children and adults from the same population. Scrub typhus can cause serious adverse effects for mother and baby in pregnancy [8]. Although homologous strain immunity persists  for  at  least  1-3  years,  immunity  to  heterologous Orientia strains is as short as 1 month. There are few data on the dynamics of IgM/IgG responses - the annual reversion of scrub typhus patients sera back to a titer of < 1  :  50 was 61% [9].

============================================================
CHUNK 7
============================================================
PATIENT EVALUATION, DIAGNOSIS, AND DIFFERENTIAL DIAGNOSIS
The majority of scrub typhus patients are not diagnosed or treated. A patient  with  fever,  headache,  and  myalgia  with  an  eschar  in  an endemic area is likely to have scrub typhus. The differential diagnosis would include spotted fever group rickettsiosis, which would also be expected to respond to tetracyclines. Scrub typhus eschars could be confused  with  the  lesions  of  anthrax,  tularemia,  chancroid,  lymphogranuloma venereum, and injury. In the absence of an eschar, few clinical  features  are  helpful.  Murine  typhus,  leptospirosis,  Q  fever, dengue, hemorrhagic fever with renal syndrome (HFRS), infectious mononucleosis, HIV seroconversion, septicemia (especially typhoid), and malaria are important differential diagnoses. In comparison with those with Q fever, Taiwanese patients with scrub typhus had a higher frequency of residence or travel in a mountainous region or offshore island,  and  skin  rash.  In  comparison  to  HFRS  in  China,  eschar, regional  lymphadenopathy  and  maculopapular  rash  were  more

TABLE 63-1 Clinical Trial and Clinical Case Series Evidence for Antibiotic Therapy for Scrub Typhus

============================================================
CHUNK 8
============================================================
PATIENT EVALUATION, DIAGNOSIS, AND DIFFERENTIAL DIAGNOSIS
Chloramphenicol 3 g every 24 h for 3 days vs tetracycline 2 g every 24 h for 3 days, Location and sample size = Vietnam (60). Chloramphenicol 3 g every 24 h for 3 days vs tetracycline 2 g every 24 h for 3 days, Outcome = Similar fever clearance times. Chloramphenicol 3 g every 24 h for 3 days vs tetracycline 2 g every 24 h for 3 days, Category = 3. Chloramphenicol 3 g every 24 h for 3 days vs tetracycline 2 g every 24 h for 3 days, Ref. = [18]. Doxycycline 200 mg stat vs tetracycline 500 mg every 6 h for 7 days, Location and sample size = Malaysia (55). Doxycycline 200 mg stat vs tetracycline 500 mg every 6 h for 7 days, Outcome = Similar fever clearance times. Doxycycline 200 mg stat vs tetracycline 500 mg every 6 h for 7 days, Category = 3. Doxycycline 200 mg stat vs tetracycline 500 mg every 6 h for 7 days, Ref. = [14]. Doxycycline 100 mg every 12 h for 3 days vs tetracycline 500 mg every 6 h for 7 days, Location and sample size = South Korea (116). Doxycycline 100 mg every 12 h for 3 days vs tetracycline 500 mg every 6 h for 7 days, Outcome = Similar fever clearance times. Doxycycline 100 mg every 12 h for 3 days vs tetracycline 500 mg every 6 h for 7 days, Category = 3. Doxycycline 100 mg every 12 h for 3 days vs tetracycline 500 mg every 6 h for 7 days, Ref. = [19]. Doxycycline 200 mg followed by 100 mg every 12 h for 7 days vs rifampicin 300 mg every 12 h for 7 days vs rifampicin and doxycycline combined in doses as above, Location and sample size = Northern Thailand (126). Doxycycline 200 mg followed by 100 mg every 12 h for 7 days vs rifampicin 300 mg every 12 h for 7 days vs rifampicin and

============================================================
CHUNK 9
============================================================
PATIENT EVALUATION, DIAGNOSIS, AND DIFFERENTIAL DIAGNOSIS
doxycycline combined in doses as above, Outcome = Rifampicin and doxycycline combined inferior to the other two single-agent groups. Fewer patients febrile at 48 h in the rifampicin group compared with the doxycycline group (RR 0.41, 95% CI 0.22-0.77). Doxycycline 200 mg followed by 100 mg every 12 h for 7 days vs rifampicin 300 mg every 12 h for 7 days vs rifampicin and doxycycline combined in doses as above, Category = 3. Doxycycline 200 mg followed by 100 mg every 12 h for 7 days vs rifampicin 300 mg every 12 h for 7 days vs rifampicin and doxycycline combined in doses as above, Ref. = [20]. Doxycycline 2.5 mg/kg every 12h, chloramphenicol 50 mg/kg/d in 3-4 doses or roxithromycin 5 mg/kg every 12h, Location and sample size = South Korea (39 children). Doxycycline 2.5 mg/kg every 12h, chloramphenicol 50 mg/kg/d in 3-4 doses or roxithromycin 5 mg/kg every 12h, Outcome = Fever clearance times not signiEcantly diFerent. Doxycycline 2.5 mg/kg every 12h, chloramphenicol 50 mg/kg/d in 3-4 doses or roxithromycin 5 mg/kg every 12h, Category = 4. Doxycycline 2.5 mg/kg every 12h, chloramphenicol 50 mg/kg/d in 3-4 doses or roxithromycin 5 mg/kg every 12h, Ref. = [21]. Azithromycin single 500 mg dose vs 200 mg doxycycline every 24 h for 7 days, Location and sample size = South Korea (93). Azithromycin single 500 mg dose vs 200 mg doxycycline every 24 h for 7 days, Outcome = Fever clearance and cure rates not signiEcantly diFerent. Azithromycin single 500 mg dose vs 200 mg doxycycline every 24

============================================================
CHUNK 10
============================================================
PATIENT EVALUATION, DIAGNOSIS, AND DIFFERENTIAL DIAGNOSIS
h for 7 days, Category = 3. Azithromycin single 500 mg dose vs 200 mg doxycycline every 24 h for 7 days, Ref. = [15]. Telithromycin 800 mg every 24 h for 5 days vs doxycycline 100 mg every 12 h for 5 days, Location and sample size = South Korea (92). Telithromycin 800 mg every 24 h for 5 days vs doxycycline 100 mg every 12 h for 5 days, Outcome = Fever clearance and cure rates not signiEcantly diFerent. Telithromycin 800 mg every 24 h for 5 days vs doxycycline 100 mg every 12 h for 5 days, Category = 3. Telithromycin 800 mg every 24 h for 5 days vs doxycycline 100 mg every 12 h for 5 days, Ref. = [16]. Azithromycin single 1000 mg dose followed by 500 mg every 24 h for 2 days vs 200 mg doxycycline followed by 100 mg every 12 h for 7 days, Location and sample size = Thailand (57). Azithromycin single 1000 mg dose followed by 500 mg every 24 h for 2 days vs 200 mg doxycycline followed by 100 mg every 12 h for 7 days, Outcome = At 48 h after initiation of treatment, a signiEcantly higher proportion of the doxycycline-treated group were afebrile than with azithromycin-treated group (p = 0.03). Azithromycin single 1000 mg dose followed by 500 mg every 24 h for 2 days vs 200 mg doxycycline followed by 100 mg every 12 h for 7 days, Category = 3. Azithromycin single 1000 mg dose followed by 500 mg every 24 h for 2 days vs 200 mg doxycycline followed by 100 mg every 12 h for 7 days, Ref. = [3]
Category 1, double blind study; 2, clinical trial < 20 subjects; 3, clinical trial > 20 subjects; 4, series; 5, anecdotal case reports. CI, conEdence interval; RR, relative risk. All clinical trials involved random allocation of treatment.

============================================================
CHUNK 11
============================================================
PATIENT EVALUATION, DIAGNOSIS, AND DIFFERENTIAL DIAGNOSIS
commonly found in patients with scrub typhus. In Laos, the presence of peripheral lymphadenopathy, chest signs and eschars are clinically useful signs that suggest scrub, rather than murine, typhus [2].
Laboratory diagnosis of scrub typhus is difficult. Culture (requiring BSL3 facilities) is 100% specific, but has low sensitivity. Immunofluorescence (IFA)  and immunoperoxidase IgM and IgG antibody tests have been commonly used, but these are expensive, rarely accessible and are bedevilled by subjectivity of interpretation and uncertainty as to the most appropriate cut-off titers in different communities [10]. Ideally, they should be interpreted by comparing titers between paired acute and convalescent samples. Karp, Gilliam, and Kato prototypic antigens are usually used in IFAs and therefore may not detect antibodies to other strains. The Weil-Felix OXK test is still commonly used in Asia, but has low sensitivity. Conventional and quantitative realtime PCR assays for the detection of O. tsutsugamushi in blood, eschar tissue, and CSF have been developed [1 1, 12]. However, there remain great difficulties in the accessibility of the diagnosis of scrub typhus in rural endemic areas. Mixed infections may occur with, for example, leptospirosis but, given the persistence of antibodies, distinguishing these  from  serial  infections  without  culture  or  PCR  techniques  is difficult.

============================================================
CHUNK 12
============================================================
TREATMENT
Given the difficulties of making a timely laboratory diagnosis and the significant minority who develop severe disease, empirical treatment should be considered for all cases with scrub typhus in the differential diagnosis. The diversity of O. tsutsugamushi suggests it is unlikely that one treatment regimen will be appropriate across the wide distribution  of  this  organism.  Chloramphenicol-  and  doxycycline-resistant scrub typhus have been described in northern Thailand [13], but there are no subsequent published data on this clinical problem.
Interpretation  of  data  informing  treatment  decisions  is  difficult,  as studies are few, often of small sample size and 'relapses' were usually not proven to be relapses of scrub typhus, rather than another cause of fever (Table 63-1). Current data suggest that fluoroquinolones are inferior to doxycycline as therapy for scrub typhus. For uncomplicated disease, the data available do not allow generalizable conclusions of the  duration  of  doxycycline  therapy  or  whether  a  loading  dose  is required. In Laos and Thailand, a 7-day treatment course of 2 mg/kg twice daily after a loading dose of 4 mg/kg is administered. There is evidence from Malaysia that shorter courses may be efficacious [14]. Upper gastrointestinal side effects are common; patients should be counseled to take doxycycline with plenty of fluid, during meals, and while sitting or standing. Chloramphenicol, telithromycin, rifampicin, and azithromycin are potential alternatives [15-20].
There are few data to guide the antibiotic treatment of severe disease - parenteral or nasogastric doxycycline or chloramphenicol are potential  options. Appropriate supportive care is essential. The treatment of  scrub  typhus  in  pregnancy  is  problematic  -  chloramphenicol (although contraindicated  in  the  last  trimester),  azithromycin,  and rifampicin have been used. In children, the risks of short-course doxycycline are almost certainly exceeded by the benefit of effective cure. In a retrospective analysis of children with scrub typhus, no significant differences in fever clearance times were found between doxycycline, chloramphenicol, or roxithromycin therapy [21].

============================================================
CHUNK 13
============================================================
TREATMENT
Mortality is very variable, ranging from 0-60% in untreated patients, for  reasons  that  are unclear. Delayed administration of doxycycline has  been  associated  with  major  organ  dysfunction  and  prolonged hospitalization, emphasizing the importance of early empirical doxycycline therapy. Relapse was described during volunteer experiments in Malaysia, but whether this is an important phenomenon in clinical practice is uncertain. Insecticides have been used to control chiggers, both in high-risk habitats and on blankets and clothes, but neither
are currently practical in rural Asia for farmers (who are at most risk of scrub typhus). For short-term adult visitors, weekly 200 mg doxycycline reduces the risk of contracting scrub typhus. There is currently no safe and effective vaccine available.

============================================================
CHUNK 14
============================================================
REFERENCES
1. Kelly DJ, Fuerst PA, Ching WM, Richards AL. Scrub typhus: the geographic distribution of phenotypic and genotypic variants of Orientia tsutsugamushi . Clin Infect Dis 2009;48(suppl. 3):S203-30.
2. Phongmany  S,  Rolain  JM,  Phetsouvanh  R,  et  al.  Rickettsial  infections  and fever, Vientiane, Laos. Emerg Infect Dis 2006;12:256-62.
3. Phimda K, Hoontrakul S, Suttinont C,  et al. Doxycycline versus  azithromycin  for  treatment  of  leptospirosis  and  scrub  typhus.  Antimicrob  Agents Chemother 2007;51:3259-63.
4. Kweon SS, Choi JS, Lim HS, et al. A community-based case-control study of behavioral factors associated with scrub typhus during the autumn epidemic season in South Korea. Am J Trop Med Hyg 2009;80:442-6.
5. Sonthayanon P, Chierakul W, Wuthiekanun V, et al. Association of high Orientia tsutsugamushi DNA loads with disease of greater severity in adults with scrub typhus. J Clin Microbiol 2009;47:430-4.
6. Paris DH, Jenjaroen K, Blacksell SD, et al. Differential patterns of endothelial and leucocyte activation in 'typhus-like' illnesses in Laos and Thailand. Clin Exp Immunol 2008;153:63-7.
7. Pai H, Sohn S, Seong Y, et al. Central nervous system involvement in patients with scrub typhus. Clin Infect Dis 1997;24:436-40.
8. Mathai  E,  Rolain  JM,  Verghese  L,  et  al.  Case  reports:  scrub  typhus  during pregnancy in India. Trans R Soc Trop Med Hyg 2003;97:570-2.
9. Saunders JP, Brown GW, Shirai A, Huxsoll DL. The longevity of antibody to Rickettsia tsutsugamushi in patients with confirmed scrub typhus. Trans R Soc Trop Med Hyg 1980;74:253-7.

============================================================
CHUNK 15
============================================================
REFERENCES
10.  Blacksell SD, Bryant NJ, Paris DH, et al. Scrub typhus serologic testing with the indirect immunofluorescence method as a diagnostic gold standard: a lack of consensus leads to a lot of confusion. Clin Infect Dis 2007;44:391-401.
11.  Paris DH, Aukkanit N, Jenjaroen K, et al. A highly sensitive quantitative realtime  PCR  assay  based  on  the  groEL  gene  of  contemporary  Thai  strains  of Orientia tsutsugamushi . Clin Microbiol Infect 2009;15:488-95.
12.  Paris  DH,  Blacksell  SD,  Newton  PN,  Day  NP.  Simple,  rapid  and  sensitive detection  of Orientia  tsutsugamushi by  loop-isothermal  DNA  amplification. Trans R Soc Trop Med Hyg 2008;102:1239-46.
13.  Watt  G,  Chouriyagune  C,  Ruangweerayud  R,  et  al.  Scrub  typhus  infections poorly  responsive  to  antibiotics  in  northern  Thailand.  Lancet  1996;348: 86-9.
14.  Brown GW, Saunders JP, Singh SL, et al Single dose doxycycline therapy for scrub typhus. Trans R Soc Trop Med Hyg 1978;72:413-6.
15.  Kim  YS,  Yun  HJ,  Shim  SK,  et  al.  A  comparative  trial  of  a  single  dose  of azithromycin  versus  doxycycline  for  the  treatment  of  mild  scrub  typhus. Clin Infect Dis 2004;39:1329-35.
16.  Kim DM, Yu KD, Lee JH, et al. Controlled trial of a 5-day course of telithromycin  versus  doxycycline  for  treatment  of  mild  to  moderate  scrub  typhus. Antimicrob Agents Chemother 2007;51:2011-5.
17.  Panpanich R, Garner P. Antibiotics for treating scrub typhus. Cochrane Database Syst Rev 2002;CD002150.
18.  Sheehy TW, Hazlett AD, Turk RE. Scrub typhus: A comparison of chloramphenical and tetracycline in its treatment. Arch Int Med 1973;132:77-80.

============================================================
CHUNK 16
============================================================
REFERENCES
19.  Song JH, Lee C, Chang LW, et al. Short course doxycycline treatment versus conventional tetracycline therapy for scrub typhus: A multiple randomized trial. Clin Infect Dis 1995;21:506-10.
20.  Watt G, Kantipong P, Jongsakul K, et al. Doxycycline and rifampicin for mild scrub-typhus  infections  in  northern  Thailand:  a  randomised  trial.  Lancet 2000;356:1057-61.
21.  Lee  KY,  Lee  HS,  Hong  JH,  et  al.  Roxithromycin  treatment  of  scrub  typhus (tsutsugamushi disease) in children. Pediatr Infect Dis J 2003;22:130-3.

